AMYLOID SOLUTION
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments. The company focuses on pathophysiological events related to disease progression and its underlying mechanism to find novel therapeutics, enabling clients with the best solution for Alzheimer disease.
AMYLOID SOLUTION
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Status:
Active
Contact:
+82-31-8092-3800
Email Addresses:
[email protected]
Total Funding:
27.44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Mobile Non Scaleable Content ReCAPTCHA Cloudflare JS CDN JS AJAX Libraries API JQuery CDN
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Biopalette
Biopalette is a operator of a platform intended to offer gene-editing techniques.
Current Employees Featured
Founder
Investors List
Kclavis
Kclavis investment in Series B - Amyloid Solution
Korea Development Bank
Korea Development Bank investment in Series B - Amyloid Solution
Yuhan Corporation
Yuhan Corporation investment in Series B - Amyloid Solution
TS Investment
TS Investment investment in Series B - Amyloid Solution
WONIK Investment Partners
WONIK Investment Partners investment in Series A - Amyloid Solution
StarTec Investments
StarTec Investments investment in Series A - Amyloid Solution
TS Investment
TS Investment investment in Series A - Amyloid Solution
KTB Network
KTB Network investment in Series A - Amyloid Solution
Innopolis Partners
Innopolis Partners investment in Series A - Amyloid Solution
Saehan Startup Investment
Saehan Startup Investment investment in Series A - Amyloid Solution
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-11-02 | Deargen | Amyloid Solution investment in Seed Round - Deargen | 3 B KRW |